TY  - GEN
AU  - Biswas,G
AU  - Parikh,P M
AU  - Nair,R
AU  - Bhagwat,R
AU  - Bakshi,A
AU  - Prabhash,K
AU  - Vora,A
AU  - Gupta,S
AU  - Pai,V R
AU  - Menon,H
AU  - Sastry,P S R K
TI  - Rituximab (anti-CD20 monoclonal antibody) in lymphoproliferative malignancies: Tata Memorial experience
SN  - 0004-5772
PY  - 2006///0605
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antigens, CD20
KW  - drug effects
KW  - Antineoplastic Agents
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - India
KW  - Lymphoma, Non-Hodgkin
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - Retrospective Studies
KW  - Rituximab
KW  - Survival Rate
N1  - Publication Type: Journal Article
ER  -